1. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. Issue 7 (July 2017) Authors: Cameron, David; Morden, James P; Canney, Peter; Velikova, Galina; Coleman, Robert; Bartlett, John; Agrawal, Rajiv; Banerji, Jane; Bertelli, Gianfilippo; Bloomfield, David; Brunt, A Murray; Earl, Helena; Ellis, Paul; Gaunt, Claire; Gillman, Alexa; Hearfield, Nicholas; Laing, Robert; Murray, Nichol... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Issue 10024 (19th March 2016) Authors: James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman,... Journal: Lancet Issue: Volume 387:Issue 10024(2016) Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10274 (13th February 2021) Authors: Abaleke, Eugenia; Abbas, Mustafa; Abbasi, Sadia; Abbott, Alfie; Abdelaziz, Ashraf; Abdelbadiee, Sherif; Abdelfattah, Mohamed; Abdul, Basir; Abdul Rasheed, Althaf; Abdul-Kadir, Rezan; Abdulmumeen, Abdulfatahi; Abdulshukkoor, Niyaz; Abdusamad, Kula; Abed El Khaleq, Yazeed; Abedalla, Mai; Abeer Ul A... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdullah, Abdullah; Abdulmumeen, Abdu... Journal: Lancet Issue: Volume 399:Issue 10325(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. (20th March 2014) Authors: Javed, Saqib; Chadwick, Eliot; Edwards, Albert A.; Beveridge, Sabeena; Laing, Robert; Bott, Simon; Eden, Christopher; Langley, Stephen Journal: BJU international Issue: Volume 114:Number 4(2014:Oct.) Page Start: 541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Favourable long‐term outcomes with brachytherapy‐based regimens in men ≤60 years with clinically localized prostate cancer. (28th May 2013) Authors: Edwards, Albert; Laing, Robert; Langley, Stephen Journal: BJU international Issue: Volume 111:Number 8(2013:Apr.) Page Start: 1181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hemi-gland focal low dose rate prostate brachytherapy: An analysis of dosimetric outcomes. Issue 2 (November 2016) Authors: Laing, Robert; Franklin, Adrian; Uribe, Jennifer; Horton, Alex; Uribe-Lewis, Santiago; Langley, Stephen Journal: Radiotherapy and oncology Issue: Volume 121:Issue 2(2016:Nov.) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Hemi‐ablative low‐dose‐rate prostate brachytherapy for unilateral localised prostate cancer. (23rd December 2019) Authors: Langley, Stephen; Uribe, Jennifer; Uribe‐Lewis, Santiago; Franklin, Adrian; Perna, Carla; Horton, Alex; Cunningham, Melanie; Higgins, Donna; Deering, Claire; Khaksar, Sara; Laing, Robert Journal: BJU international Issue: Volume 125:Number 3(2020) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 401:Issue 10387(2023) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗